Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Colony-Stimulating Factors × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 5 Triple Negative Breast Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Ganglioneuroblastoma 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Neoplasm Metastasis 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Adenoma, Islet Cell 1

Interventions

pembrolizumab 36 Cyclophosphamide 21 Bevacizumab 16 Standard of Care 12 Nivolumab 12 Carboplatin 12 Blood Specimen Collection 12 atezolizumab 11 Paclitaxel 10 Doxorubicin 10 Rituximab 9 Pemetrexed 9 Interviews as Topic 9 Fluorouracil 9 fludarabine 8 Prednisone 8 Dexamethasone 8 Surveys and Questionnaires 7 Radiotherapy 7 Oxaliplatin 7 Leucovorin 7 venetoclax 6 olaparib 6 durvalumab 6 Letrozole 6 Fulvestrant 6 Exercise 6 Biopsy 6 pertuzumab 5 palbociclib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05421897 2026-01-29

RAPID

Children's Hospital Los Angeles

Phase 1 Active not recruiting

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡